Quest Diagnostics Incorporated (DGX) compared with its closest peers (LH, FTRE, NTRA, RDNT, GH): P/E 25.4 vs industry 25.4. Peer set by Healthcare Services; 10 comparable companies. First-party data.
Labcorp, Fortrea, Natera, RadNet, Guardant Health, Lumexa Imaging Holdings, Inc. Common Stock, Caris Life Sciences and Veracyte share Quest Diagnostics's sub-industry, medical laboratories.
| Company | Market Cap | P/E |
|---|---|---|
| Labcorp Holdings Inc. (LH) | $27.39B | 24.6 |
| Fortrea Holdings Inc. (FTRE) | $1.74B | -1.6 |
| Natera, Inc. (NTRA) | $48.53B | -150.7 |
| RadNet, Inc. (RDNT) | $6.05B | -285.0 |
| Guardant Health, Inc. (GH) | $22.13B | -30.8 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.13B | 656.4 |
| Caris Life Sciences, Inc. (CAI) | $7.91B | -8.4 |
| Veracyte, Inc. (VCYT) | $3.52B | 30.7 |
| Community Health Systems, Inc. (CYH) | $417.39M | 1.7 |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $11.32B | 30.9 |
| Stock P/E | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
| Industry P/E (Healthcare Services) | 25.4 |
| vs Sector | 15.8% |
| vs Industry | 0.0% |
DGX overview · DGX earnings · DGX financials · DGX KPIs · DGX documents · DGX ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.